US Patent 10988448 Therapeutic compounds and compositions
Patent 10988448 was granted and assigned to Agios Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+228 characters)
Article
Patent abstract
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109884480
Date of Patent
April 27, 2021
0Patent Application Number
162432470
Date Filed
January 9, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109884480
Date of Patent
April 27, 2021
0Patent Application Number
162432470
Date Filed
January 9, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10988448 Therapeutic compounds and compositions
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10988448
Date of patent
April 27, 2021
Patent application number
16243247
Date Filed
January 9, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10988448 Therapeutic compounds and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
